pros and cons of tirzepatide for weight loss Tirzepatide: Uses, Side Effects, Dosing, Cost & More How Tirzepatide Helps Lose Weight

Both remain in phase 3 clinical development programs [16]: Cagrilintide Status: Phase 3 trials ongoing for CagriSema (cagrilintide + semaglutide combination) Expected approval timeline: 2027-2028 for the combination product Monotherapy development pathway unclear Retatrutide Status: Phase 3 trials initiated in 2024-2025 Monotherapy development for obesity and metabolic dysfunction Expected approval timeline: 2028-2029 if trials succeed This regulatory status means any use of these compounds, whether individually or in cagrilintide dosage with retatrutide combinations, occurs in research contexts or through off-label prescribing once (if) individual approvals are obtained

Targeting populations with unmet medical needs presents a significant opportunity for successful drug launches

All formulations of Wegovy and Foundayo are approved but only the Zepbound KwikPen will be available

Always follow the guidance provided by your prescribing healthcare professional

Nausea, Mild Stomach Pain, or Gas These conditions tend to come with the territory for GLP-1 users, especially during the dose titration period where you escalate toward your specific target dosage